Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

Europe - FRA:TR1 - US74144T1088 - Common Stock

88.73 EUR
-0.76 (-0.85%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to TR1. TR1 was compared to 110 industry peers in the Capital Markets industry. TR1 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TR1 has a decent growth rate and is not valued too expensively. TR1 also has an excellent dividend rating. With these ratings, TR1 could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year TR1 was profitable.
In the past year TR1 had a positive cash flow from operations.
TR1 had positive earnings in each of the past 5 years.
Each year in the past 5 years TR1 had a positive operating cash flow.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

With an excellent Return On Assets value of 13.85%, TR1 belongs to the best of the industry, outperforming 93.64% of the companies in the same industry.
TR1 has a Return On Equity of 18.81%. This is in the better half of the industry: TR1 outperforms 77.27% of its industry peers.
TR1's Return On Invested Capital of 13.25% is amongst the best of the industry. TR1 outperforms 91.82% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TR1 is significantly above the industry average of 8.35%.
Industry RankSector Rank
ROA 13.85%
ROE 18.81%
ROIC 13.25%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

TR1's Profit Margin of 27.99% is fine compared to the rest of the industry. TR1 outperforms 73.64% of its industry peers.
In the last couple of years the Profit Margin of TR1 has declined.
With a decent Operating Margin value of 32.45%, TR1 is doing good in the industry, outperforming 76.36% of the companies in the same industry.
In the last couple of years the Operating Margin of TR1 has declined.
Industry RankSector Rank
OM 32.45%
PM (TTM) 27.99%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

TR1 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TR1 has less shares outstanding
Compared to 1 year ago, TR1 has an improved debt to assets ratio.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

TR1 has an Altman-Z score of 5.87. This indicates that TR1 is financially healthy and has little risk of bankruptcy at the moment.
TR1's Altman-Z score of 5.87 is amongst the best of the industry. TR1 outperforms 92.73% of its industry peers.
The Debt to FCF ratio of TR1 is 0.04, which is an excellent value as it means it would take TR1, only 0.04 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of TR1 (0.04) is better than 97.27% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that TR1 is not too dependend on debt financing.
The Debt to Equity ratio of TR1 (0.00) is better than 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 5.87
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

TR1 has a Current Ratio of 2.81. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.81, TR1 belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
A Quick Ratio of 2.81 indicates that TR1 has no problem at all paying its short term obligations.
The Quick ratio of TR1 (2.81) is better than 87.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 2.81
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.39% over the past year.
TR1 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.42% yearly.
Looking at the last year, TR1 shows a small growth in Revenue. The Revenue has grown by 4.43% in the last year.
TR1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.78% yearly.
EPS 1Y (TTM)7.39%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-0.88%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%-0.58%

3.2 Future

Based on estimates for the next years, TR1 will show a small growth in Earnings Per Share. The EPS will grow by 5.10% on average per year.
The Revenue is expected to grow by 1.47% on average over the next years.
EPS Next Y0.53%
EPS Next 2Y2.68%
EPS Next 3Y2.15%
EPS Next 5Y5.1%
Revenue Next Year1.25%
Revenue Next 2Y3.1%
Revenue Next 3Y2.97%
Revenue Next 5Y1.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

TR1 is valuated reasonably with a Price/Earnings ratio of 11.30.
Based on the Price/Earnings ratio, TR1 is valued a bit cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of TR1 to the average of the S&P500 Index (27.32), we can say TR1 is valued rather cheaply.
TR1 is valuated reasonably with a Price/Forward Earnings ratio of 10.53.
Based on the Price/Forward Earnings ratio, TR1 is valued cheaply inside the industry as 85.45% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, TR1 is valued rather cheaply.
Industry RankSector Rank
PE 11.3
Fwd PE 10.53
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

81.82% of the companies in the same industry are more expensive than TR1, based on the Enterprise Value to EBITDA ratio.
77.27% of the companies in the same industry are more expensive than TR1, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.42
EV/EBITDA 7.68
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TR1 does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TR1 may justify a higher PE ratio.
PEG (NY)21.43
PEG (5Y)4.68
EPS Next 2Y2.68%
EPS Next 3Y2.15%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.91%, TR1 is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.16, TR1 pays a better dividend. On top of this TR1 pays more dividend than 80.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, TR1 pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.91%

5.2 History

The dividend of TR1 is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

TR1 pays out 57.43% of its income as dividend. This is a bit on the high side, but may be sustainable.
TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.43%
EPS Next 2Y2.68%
EPS Next 3Y2.15%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (9/26/2025, 7:00:00 PM)

88.73

-0.76 (-0.85%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-23 2025-10-23/amc
Inst Owners80.56%
Inst Owner ChangeN/A
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap19.50B
Analysts49.47
Price Target90.09 (1.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.91%
Yearly Dividend4.35
Dividend Growth(5Y)10.37%
DP57.43%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.77%
Min EPS beat(2)2.66%
Max EPS beat(2)2.88%
EPS beat(4)3
Avg EPS beat(4)2.05%
Min EPS beat(4)-5.31%
Max EPS beat(4)7.98%
EPS beat(8)6
Avg EPS beat(8)5.63%
EPS beat(12)10
Avg EPS beat(12)5.14%
EPS beat(16)10
Avg EPS beat(16)2.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.98%
Max Revenue beat(2)-2.2%
Revenue beat(4)0
Avg Revenue beat(4)-3.58%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-2.2%
Revenue beat(8)2
Avg Revenue beat(8)-2.63%
Revenue beat(12)3
Avg Revenue beat(12)-1.82%
Revenue beat(16)3
Avg Revenue beat(16)-2.81%
PT rev (1m)-0.15%
PT rev (3m)8.66%
EPS NQ rev (1m)0.45%
EPS NQ rev (3m)17.01%
EPS NY rev (1m)0.18%
EPS NY rev (3m)10.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.61%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)3.91%
Valuation
Industry RankSector Rank
PE 11.3
Fwd PE 10.53
P/S 3.21
P/FCF 19.42
P/OCF 14.84
P/B 2.15
P/tB 2.99
EV/EBITDA 7.68
EPS(TTM)7.85
EY8.85%
EPS(NY)8.43
Fwd EY9.5%
FCF(TTM)4.57
FCFY5.15%
OCF(TTM)5.98
OCFY6.74%
SpS27.67
BVpS41.18
TBVpS29.64
PEG (NY)21.43
PEG (5Y)4.68
Profitability
Industry RankSector Rank
ROA 13.85%
ROE 18.81%
ROCE 17.79%
ROIC 13.25%
ROICexc 17.33%
ROICexgc 27.49%
OM 32.45%
PM (TTM) 27.99%
GM N/A
FCFM 16.51%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexcg growth 3Y-16.2%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0.02
Cap/Depr 138.78%
Cap/Sales 5.1%
Interest Coverage 250
Cash Conversion 59.81%
Profit Quality 58.97%
Current Ratio 2.81
Quick Ratio 2.81
Altman-Z 5.87
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)7.39%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-0.88%
EPS Next Y0.53%
EPS Next 2Y2.68%
EPS Next 3Y2.15%
EPS Next 5Y5.1%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%-0.58%
Revenue Next Year1.25%
Revenue Next 2Y3.1%
Revenue Next 3Y2.97%
Revenue Next 5Y1.47%
EBIT growth 1Y5.96%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year2.03%
EBIT Next 3Y3.55%
EBIT Next 5Y2.47%
FCF growth 1Y-9.3%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y-0.36%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%